BioCentury
ARTICLE | Clinical News

BioSante, Medi-Ject preclinical data

August 14, 2000 7:00 AM UTC

The companies said that a DNA vaccine encoding viral proteins formulated with BTPH's CAP technology and delivered intramuscularly with MEDJ's needle-free injection system produced significant cellular...